Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
74
datasets available to search
ShareScore release 0.9.0
Dataset results
74 results for “asymptomatic infections”
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
ClinicalTrials.gov study NCT01335191. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
ClinicalTrials.gov study NCT04847141. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
ClinicalTrials.gov study NCT01322971. IPD Sharing: Not stated. Countries: 1. Publications: 13.
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household
ClinicalTrials.gov study NCT04452318. IPD Sharing: YES. Countries: 3. Publications: 8.
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects
ClinicalTrials.gov study NCT00848211. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands
Introduction: Solomon Islands is intensifying national efforts to achieve malaria elimination. A long history of indoor spraying with residual insecticides, combined recently with distribution of long lasting insecticidal nets and artemether-lumefantrine therapy, has been implemented in Solomon Islands. The impact of these interventions on local endemicity of Plasmodium spp. is unknown. Methods: In 2012, a cross-sectional survey of 3501 residents of all ages was conducted in Ngella, Central Islands Province, Solomon Islands. Prevalence of Plasmodium falciparum, P. vivax, P. ovale and P. malariae was assessed by quantitative PCR (qPCR) and light microscopy (LM). Presence of gametocytes was determined by reverse transcription quantitative PCR (RT-qPCR). Results: By qPCR, 468 Plasmodium spp. infections were detected (prevalence=13.4%; 463 P. vivax, five mixed P. falciparum/P. vivax, no P. ovale or P. malariae) versus 130 by LM (prevalence=3.7%; 126 P. vivax, three P. falciparum and one P. falciparum/P. vivax). The prevalence of P. vivax infection varied significantly among villages (range 3.0-38.5%, p<0.001) and across age groups (5.3-25.9%, p<0.001). Of 468 P. vivax infections, 72.9% were sub-microscopic, 84.5% afebrile and 60.0% were both sub-microscopic and afebrile. Local residency, low education level of the household head and living in a household with at least one other P. vivax infected individual increased the risk of P. vivax infection. Overall, 23.5% of P. vivax infections had concurrent gametocytaemia. Of all P. vivax positive samples, 29.2% were polyclonal by MS16 and msp1F3 genotyping. All five P. falciparum infections were detected in residents of the same village, carried the same msp2 allele and four were positive for P. falciparum gametocytes. Conclusion: P. vivax infection remains endemic in Ngella, with the majority of cases afebrile and below the detection limit of LM. P. falciparum has nearly disappeared, but the risk of re-introductions and outbreaks due to travel to nearby islands with higher malaria endemicity remains.
HTLV-1 and HTLV-2 Infections Significantly Alter Small RNA Expression in Asymptomatic Carriers: A Pilot Study
<p><span>Small RNA NGS sequences from asymptomatic HTLV-2 infected individuals</span></p>
Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
ClinicalTrials.gov study NCT00000977. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections
ClinicalTrials.gov study NCT03223415. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
ClinicalTrials.gov study NCT00000736. IPD Sharing: Not stated. Countries: 1. Publications: 9.
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection
ClinicalTrials.gov study NCT06081712. IPD Sharing: NO. Countries: 1. Publications: 1.
Asymptomatic COVID-19 Infection Among Healthcare Workers
ClinicalTrials.gov study NCT04354792. IPD Sharing: NO. Countries: 1. Publications: 2.
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons
ClinicalTrials.gov study NCT04401449. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
ClinicalTrials.gov study NCT00480558. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
ClinicalTrials.gov study NCT04495699. IPD Sharing: NO. Countries: 2. Publications: 10.
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
ClinicalTrials.gov study NCT00000805. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infect
ClinicalTrials.gov study NCT00000762. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Asymptomatic Leishmania Infection in HIV Patients
ClinicalTrials.gov study NCT02839603. IPD Sharing: NO. Countries: 1. Publications: 1.
JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
ClinicalTrials.gov study NCT04780321. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
ClinicalTrials.gov study NCT01029548. IPD Sharing: Not stated. Countries: 1. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.